News
Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Eli Lilly and Company (NYSE:LLY) is experiencing a strong analyst sentiment amid its expanding role in cutting-edge ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Shona also quoted doctor Tom Hildebrandt, who said he was seeing an increase in patients with eating disorders taking ...
Explore more
Officials with the Indianapolis Public Schools recently announced that the district will receive more than $10 million from ...
Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...
Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug ...
Four months after giving Eli Lilly’s Alzheimer’s disease treatment a thumbs-down, Europe’s Committee for Medicinal Products ...
Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...
While fellow WNBA stars like Angel Reese and Cameron Brink have shown love for the dating show, Clark prefers a more low-key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results